The role of the Ah locus in hexachlorobenzene (HCB)-induced porphyria and the possible involvement of P-450 cytochromes P1450 and P3450 in the pathogenesis of 
INTRODUCTION
Several halogenated aromatic hydrocarbons (HAH), including hexachlorobenzene (HCB), 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and certain halogenated biphenyls, produce in humans and experimental animals a hepatic porphyria that closely resembles the human disease porphyria cutanea tarda [1] [2] [3] . HAH-induced porphyria is characterized by the hepatic accumulation and increased urinary excretion of highly carboxylated porphyrins [mainly uroporphyrin (URO) and heptacarboxyporphyrin]. This pattern of porphyrin overproduction is associated with a decrease in the hepatic activity of the soluble enzyme uroporphyrinogen decarboxylase (UD; EC 4.1.1.37) [1, 3] .
The exact mechanism by which UD activity is diminished in HAH-induced porphyria has not yet been elucidated. An alteration in the synthesis or degradation of the enzyme is possible, although there is some evidence that the amount of enzyme protein is unchanged after treatment with HCB or TCDD [4] . An alternative hypothesis is that a reactive metabolite of HCB or TCDD may inactivate UD, perhaps by binding covalently to the enzyme [2, 5] . However, no covalent binding of ['4C ]HCB-derived radioactivity to UD has been detected [6] , and the porphyrogenic potency of TCDD [7, 8] , coupled with its resistance to metabolism [9] , makes this hypothesis unlikely. It has also been suggested that the induction of one or more isoenzymes of hepatic cytochrome P-450 may be involved in the pathogenesis of HAH-induced porphyria, via the production of reactive species of oxygen or in association with lipid peroxidation [3, 6, [10] [11] [12] [13] . Two P450 isoenzymes in particular are induced by all of the porphyrogenic HAHs (see below).
Most of the toxic effects of TCDD and structurally related compounds appear to be mediated by a specific interaction with the Ah receptor, the regulatory gene product of the Ah locus [14, 15] . {The Ah locus was originally defined as the locus (loci) controlling the induction of cytochrome P-450-mediated multisubstrate mono-oxygenase activities (e.g. AHH) by polycyclic aromatic hydrocarbons such as 3MC, and was said to include structural, regulatory, and possibly temporal, genes [15] . In current usage, 'Ah locus' (or 'Ah gene') refers to the gene or genes encoding the Ah receptor protein. In crosses between C57BL/6 and DBA/2 mice, Ah-responsiveness is inherited in a dominant fashion; the pattern of inheritance is more complex in other strains [15] [16] [17] .} Included among these receptor-mediated effects of TCDD are the aforementioned hepatic porphyria [7] and the induction in rats and mice of two hepatic cytochrome P-450 isoenzymes, P450c (P1450) and P450d (P3450) [18, 19] . ( The nomenclature used to describe the cytochrome P-450 isoenzymes is that of Thomas et al. [18] for rats and that of Kimura et al. [19] for mice. P450c and P450d of rats are orthologous to mouse P1450 and P3450 respectively [19] ; these proteins are encoded by the rodent P4501A1 and P450IA2 genes respectively [20] .} HCB produces an identical hepatic porphyria [1, 2, 21] and induces P450c and P450d in rats (although, in contrast with TCDD, HCB induces P450d preferentially) [22] . The similarity of the effects of HCB to those of TCDD is somewhat surprising, since HCB does not appear to obey the structural requirements thought to govern the binding of compounds to the Ah receptor [14, 23] . Although HCB inhibits the specific binding of [3H]TCDD to the Ah receptor in vitro [22] , the concentrations required (10-6-10-5 M-HCB) are quite high in comparison with those of known ligands for the Ah receptor and may therefore reflect non-specific effects of HCB on the solubility of TCDD. Alternatively, HCB may possess weak binding activity.
To examine the role of the Ah locus in TCDD-or HCB-induced porphyria, previous investigators have taken advantage of allelic differences at this locus, and the resulting differences in the properties of the Ah receptor, that exist among inbred strains of mice. C57BL/6 mice ('Ah-responsive') possess a high-affinity hepatic Ah receptor, whereas DBA/2 mice ('Ah-nonresponsive') possess fewer receptors and/or receptors with a diminished affinity for TCDD and related compounds [14, 15] . Several effects of TCDD have been shown to segregate with the Ah-responsive phenotype in crosses and back-crosses of these two strains [14] . Similarly, both TCDD and HCB produce porphyria in C57BL/6 (B6) mice, but not in DBA/2 (D2) mice [7, 24] . Studies in other strains, however, have shown an incomplete correlation between the Ah phenotype and susceptibility to TCDD-or HCB-induced porphyria [8, 21] . Interpretation of these results is complicated by the many other genetic differences that exist between these strains of mice [9, 25, 26] . In order to eliminate these differences, we utilized congenic strains of C57BL/6J mice that differ only at the Ah locus and a limited number of loci closely linked to the Ah locus (see [27] for a review of the genetics of congenic mice). Congenic C57BL/6J mice have also been used recently by other investigators to study the pharmacokinetics [25] and immunotoxicity [28] of TCDD, the characteristics of the Ah receptor [29] , and the induction of cytochrome P-450 isoenzymes by HCB [30] and isosafrole [31] . The present study shows that B6-Ahb (Ah-responsive) mice are more susceptible to the porphyrogenic effect of HCB than are congenic B6-Ahd (Ah-non-responsive) mice and that this difference in susceptibility is associated with diferences in the inducibility of two cytochrome P-450 isoenzymes.
Part 
Animals
Female C57BL/6J (B6-Ahb) mice were purchased from Jackson Laboratories (Bar Harbor, ME, U.S.A.). Female congenic B6-Ahd mice were generously provided by Dr. Linda S. Birnbaum (National Institute ofEnvironmental Health Sciences). These mice were originally bred in the laboratory of Dr. Daniel W. Nebert (National Institutes of Health, Bethesda, MD, U.S.A.) [34] using the cross-intercross method [27] , whereby the Ah-nonresponsive phenotype (Ahd allele) of DBA/2N mice was bred on to a C57BL/6N background. These congenic mice were B6N.D2N-Ahd(NE13) when obtained from Dr. Nebert samples by ion-exchange chromatography. Urine samples were applied to a 0.7cmx7.0cm column of Dowex IX8-100 resin that had been previously equilibrated with deionized water containing NaN3 (0.1 g/l). Alto, CA, U.S.A.) and a Perkin-Elmer LC-10 fluorescence detector (Perkin-Elmer, Norwalk, CN, U.S.A.) with excitation and emission filters of 360 nm and 500-700 nm respectively. The columns were maintained at 20 'C. Peak areas were quantified by using a Perkin-Elmer LCI-100 laboratory computing integrator. H.p.l.c. solvents were as described by Ford et al. [36] and were degassed with helium immediately before use. By using this method, recovery of porphyrins added to control urine samples was 94 + 4 %.
Hepatic porphyrins
The method of Kennedy et al. [37] was used to extract porphyrins from hepatic homogenates. The extracted porphyrins were then analysed by h.p.l.c. as described above. Recovery of porphyrin standards added to hepatic homogenates from untreated mice averaged 95 + 3 % for the five porphyrins. Hepatic HCB concentrations Aliquots of the hepatic homogenate were suspended in hexane and analysed for HCB by gas chromatography using a Perkin-Elmer Sigma 2000 gas chromatograph with a flame-ionization detector heated to 270 'C. The column (20% SP-2100/0.1% Carbowax 1500) was operated at 190°C with nitrogen (30ml/min) as the carrier gas. The mean recovery of HCB added at 100, 500 and 1000 jg/g was 97 + 17 %.
Hepatic lipids
Hepatic lipid concentrations were determined gravimetrically after extraction of -1 ml of homogenate (equivalent to -167 mg of tissue) with 9 ml of chloroform/methanol (2: 1, v/v) as described by Folch et al. [38] . [39] . URO III octamethyl ester was hydrolysed in 5 M-HCI (-1.6 mg of URO ester/ml of HCI) for 24 h in the dark at room temperature. After evaporation of the acid in vacuo over KOH, the URO was dissolved in lOO,ul of NH40H (1.0 M) and diluted to a final concentration of 1-2 mM-URO in 0.05 M-NH40H. This stock solution was stable for several months in the dark at 4 OC. Just before assay, the URO was reduced to URO'gen with NaBH4. To 150 pl of the URO stock were added five or six drops of 1.0 M-NaBH4, followed by two or three drops of 0.5 M-HCI. After 30-60 min (and several colour changes) at 4°C under helium and red light, the porphyrin was completely reduced (95 % minimum; routinely > 98 %), as indicated by its lack of fluorescence. Cold 1.0 mM-EDTA/3 mM-dithiothreitol/ 0.1 M-potassium phosphate buffer, pH 6.8, was then added to a final volume of 1.0 ml. This URO'gen solution was kept under helium until used (usually within 30 min).
In order to avoid interference with the assay and possible inhibition of UD by the elevated concentrations of endogenous porphyrins in livers from HCB-treated mice [40] , porphyrins were removed from the cytosol by adsorption on to an anion-exchange resin [41] . A 2 ml portion of a 50% (v/v) suspension of Dowex lX8-400 in 0.25 M-sucrose was added to a clean test tube. The resin was pelleted (1000 g for O min) and the excess sucrose drawn off. A 1 ml portion of cytosol was added, mixed with the resin, and incubated at 4°C for 15 min with occasional mixing. After centrifuging for 10 min at 1000 g, the cytosol was removed for use in the assay. This procedure removed more than 95 % of the endogenous porphyrins from the cytosol of porphyric mice.
For the UD assay, 750 #1 of0.1 M-potassium phosphate buffer, pH 6.8, 200,l of cytosol (1.1-1.3 mg of protein), and 50 u1 of URO'gen (final concn. 7.5-9.1 /SM) were added to amber-glass vials. After addition of substrate, the reaction was started by transferring the vials to a 37°C shaking water bath. After a 30 min incubation under helium and red light, the reaction was stopped by placing the vials on ice and immediately (< 15 s) adding 500,ul of cold 3 M-HCI. After being transferred to clear test tubes, the reaction mixtures were left overnight at 4°C and then centrifuged at 700 g for 5 min. The porphyrins in the supernatant were separated and quantified by h.p.l.c. as described above. The major product formed under these conditions was heptacarboxyporphyrin. UD activity is expressed as the sum ofall ofthe porphyrins formed, i.e. the decarboxylation of URO'gen. Product formation was linearly related to protein concentration (0.5-1.5 mg/ml) and incubation time (5-30 min) over the specified ranges. Cytochrome P450 isoenzymes Antisera to the immunochemically similar rat cytochrome P-450 isoenzymes P450c and P450d were raised in rabbits and immunoadsorbed with the heterologous antigen to remove cross-reactivity of anti-P450c to P450d and of anti-P450d to P450c [42, 43] . SDS/polyacrylamide-gel electrophoresis (7.5 % acrylamide) of mouse hepatic microsomal protein was performed as described by Laemmli [44] . Proteins were then electrophoretically transferred to nitrocellulose sheets by the method of Towbin et al. [45] and immunostained with immunospecific anti-P450c or anti-P450d [42] . In hepatic microsomes from 3MC-induced B6-Ahb mice, anti-P450c recognized primarily a single band whose mobility was similar to that of P450c ( Fig. 3; [22] ), whereas anti-P450d recognized a polypeptide with a mobility equivalent to that of P450d [22] . The mouse hepatic microsomal proteins recognized by anti-P450c and anti-P450d are presumably identical with P1450 and P3450 respectively, since there is 93 % amino acid sequence similarity between P1450 and P450c and between P3450 and P450d [19] .
The relative amounts of P1450 and P3450 in hepatic microsomes were measured in radioimmunoassays (r.i.a.) by competition with`23I-P450c and 125I-P450d respectively [43] . Purified P450d was used to generate the standard curve for the r.i.a. of P3450. Since preliminary studies indicated that microsomal P1450 competed poorly in the r.i.a. compared with rat hepatic microsomal P450c, solubilized microsomes from 3MC-induced mice were used for the P1450 standard curve rather than P450c. Solubilized microsomes from these mice inhibited the binding of both 1251-P450c and 1251-P450d by their respective antibodies, and the inhibition curves were parallel with those generated with pure P450c and pure P450d, indicating that the assays of P1450 and P3450 were linear and valid. All results are presented as relative amounts of P1450 or P3450, with the mean of all control values (for each isoenzyme) set equal to 1.0. Protein Microsomal protein was measured by the method of Lowry et al. [46] . The spectrophotometric method of Waddell [47] was used to measure cytosolic protein, bovine serum albumin being used as standard.
Data analysis
Statistical analyses were performed to compare HCBtreated groups with their controls or to compare the 15-week HCB-treated B6-Ahb and B6-Ah" groups [48] . An F test was used to test the homogeneity of variance, after which the appropriate t test was utilized to determine the probability that the observed difference in the means could have occurred by chance. Data are reported as means + S.D.
RESULTS AND DISCUSSION Food consumption and body weights
The total amounts of food consumed during the study by HCB-treated B6-Ahb and B6-Ahd mice were similar, and represented a total dose of approx. 2.9 and 3.0 g of HCB/kg body wt. respectively after 15 weeks of treatment (results not shown). Since one of the characteristic toxic effects of TCDD is a loss of body weight and mobilization of adipose tissue ('wasting syndrome') [14] , mice were weighed twice each week to determine if HCB had a similar effect. No differences in body weight were seen between control and HCB-treated mice (Table 1) . Urinary porphyrins HCB-induced porphyria developed sooner and was much more severe in B6-Ahb mice than in B6-Ahd mice. Urinary porphyrin excretion began to increase after 7 weeks of HCB treatment in B6-Ahb mice and was elevated 200-fold after 15 weeks (Fig. Ic) . In addition, URO replaced coproporphyrin as the major urinary porphyrin from 7 weeks onward (Fig. la) . In B6-Ahd mice, urinary porphyrin excretion did not begin to increase until after 13 weeks of HCB treatment and was elevated only 6-fold after 15 weeks. URO did not become the dominant porphyrin until after 14 weeks in these mice, and even after 17 weeks represented only 50 0 of 1988 
Hepatic porphyrins and U-D activity
The differences seen in urinary porphyrin excretion were confirmed by measuring hepatic porphyrin concentrations and UD activity. After 15 weeks of treatment, the relative increases in hepatic porphyrins in B6-Ahb and B6-Ahd mice were 5550-fold versus 73-fold respectively (Table 1) . URO and heptacarboxyporphyrin comprised most (> 97 %) of the porphyrins (Fig. 2) . The increased content of hepatic porphyrins was also observed by fluorescence microscopy (results not shown). After 9 weeks of HCB treatment, sections from B6-Ahb mice exhibited focal areas of red fluorescence surrounded by non-fluorescent tissue. After 15 weeks, intense red fluorescence was seen throughout. Sections from B6-Ahd mice given HCB for 15 or 17 weeks displayed focal fluorescence similar to that seen in the B6-Ahb-9-week mice. No red fluorescence was observed in control mice of either strain. After 15 weeks, the hepatic UD activity of HCB-treated B6-Ahb mice was diminished by 70 % (P = 0.0001)compared with that ofcontrol mice, whereas for B6-Ahd mice the observed decrease was only 20 % (P = 0.030) ( [50] , consistent with the ability of relatively high doses of TCDD to induce P1450 and P3450 in these mice. It is likely that the B6-Ah4 mice used in the present study possess the same 'defective' receptor Vol. 254 found in DBA/2 mice. This might explain the modest porphyria that we observed in these mice. Although Smith & Francis [21] reported that DBA/2 mice did not become porphyric after treatment with iron-and HCB, they maintained treatment for only 12 weeks. The B6-Ahd mice used in our study were exposed for up to 17 weeks, and elevated porphyrin levels were not seen until after 13 weeks (Fig. 1) . Moreover, DBA/2 mice may be resistant to HAH-induced porphyria as compared with B6-Ahd mice, perhaps because of their greater adiposetissue content [9, 25] or resistance to peroxidative events [6, 51] . Hepatic HCB concentrations
As shown in Table 3 , hepatic HCB levels, when expressed per g of liver, were almost three times greater in B6-Ahb mice than in B6-Ahd mice after 15 weeks, despite the similar food consumption of the two strains. However, livers from HCB-treated B6-Ahb mice contained more lipid than those of B6-Ah4 mice, as assessed biochemically (Table 3 ) and histologically (Oil Red 0 stain; results not shown). Similar elevations in hepatic lipids have been seen in C57BL/10 mice treated with HCB [21] or TCDD [8] . In the present study, hepatic HCB levels in the two strains were not significantly different (P = 0.12) when expressed relative to hepatic lipid content ( Table 3 ), suggesting that the higher HCB levels seen in B6-Ahb mice as compared with B6-Ahd mice could be due in part to the greater accumulation of hepatic lipids in the former strain.
Induction of cytochrome P450 isoenzymes
Because of the previously noted association between the induction of certain isoenzymes of hepatic cytochrome P-450 and HAH-induced porphyria, we measured the amounts of P1450 and P3450 by immunoblotting and radioimmunoassay (Figs. 3 and 4) . No polypeptide was recognized by anti-P450c in control B6-Ahb or B6-Ahd microsomes. HCB induced a polypeptide recognized by anti-P450c (P1450) in hepatic microsomes of B6-Ahb mice, but to a lesser extent than acute treatment with 3MC (Fig. 3a) . However, P1450 was not induced in hepatic microsomes of HCB-treated B6-Ahd mice.
The immunoblotting results were confirmed by radioimmunoassay (Fig. 4a) , P1450 was induced 16-36-fold by HCB in B6-Ahb mice, whereas no significant induction analysed; the samples shown are those whose total porphyrin concentrations were closest to the mean value for their group. The treatment period was 15 weeks in each case. Vertical bars in the ordinate position represent equivalent relative fluorescence. Key to numbers: 8, URO; 7, heptacarboxyporphyrin; 6, hexacarboxyporphyrin; 5, pentacarboxyporphyrin; 4, coproporphyrin; 2, mesoporphyrin.
was observed in B6-Ahd mice. The magnitude of the increase measured by r.i.a. in the B6-Ahb mice reflects the very low constitutive levels of this isoenzyme. The level of P1450 induction produced in B6-Ahb mice after 9 or 15 weeks of treatment with 200 p.p.m. of HCB is much lower than the 70-fold increase seen after administration of 3MC for 3 days [22, 30] . However, the increase is greater than that seen after short-term treatment (7 days) with 1000 p.p.m. of HCB (5-fold) [22, 30] . This suggests that the induction of P1450 may require hepatic levels of HCB higher than those attained during the 7-day protocol, or that the increase in P1450 produced by long-term exposure to HCB might reflect secondary changes in the regulation of this isoenzyme.
Equivalent amounts of a polypeptide recognized by anti-P450d (P3450) were present in control B6-Ahb and B6-Ahd mice (Figs. 3b and 4b) . HCB induced relatively large amounts of this polypeptide in both strains; however, induction of P3450 was greater in B6-Ahb mice than in B6-Ahd mice (12- [8, 21, 24] . The susceptibility of the AKR strain to HCBinduced porphyria [21] is not inconsistent with our data. This strain is classified as Ah-non-responsive on the basis of the inability of 3MC to induce AHH activity (P1450) and the absence of detectable Ah receptor [15] ; induction of P3450 has not been investigated in these mice. Genetic studies suggest, however, that the AKR and DBA/2 strains do not carry the same Ah allele [15, 16] Immunoblots were prepared as described previously- [22, 42] , using antisera raised against rat isoenzymes P450c (a) and P450d (b) to identify mouse cytochromes P1450 and P3450 respectively in microsomes from control (Con) or HCB-treated (HCB) mice after 9, 15, or 17 weeks (w) of treatment. Samples contained 40 ,ug of microsomal protein, except as noted below. P450c, purified rat hepatic P450c (2 pmol); 3MC, microsomal protein (10 ,ug) from B6-Ahb mice treated with 80 mg of 3MC *day-'1 kg-1 for 3 days; P450d, purified rat hepatic P450d (2 pmol). It has been suggested that the pathogenesis of HAHinduced porphyria might involve the cytochrome P-450 system. According to one hypothesis, reactive oxygen species, such as superoxide and H202, are produced by cytochrome P-450 and either inactivate UD or oxidize its porphyrinogen substrates to the non-metabolizable porphyrins [6, 10, 11, 55, 56] . This hypothesis provides a possible explanation for the obligatory role of iron in HAH-induced porphyria [12,2 1] , in that iron may catalyse the formation of hydroxyl radicals from H202 and superoxide (the Haber-Weiss reaction) [57] . The release of superoxide and H202 has been observed during the autoxidation of cytochrome P-450 isoenzymes and may be increased in the presence of a substrate for the cytochrome P-450 [58] or after covalent modification of a specific isoenzyme [59] .
The role of the Ah locus, then, might be to control the induction of an isoenzyme of cytochrome P-450 that can participate in such reactions. Two specific isoenzymes, P1450 and P3450, are induced in common by HCB, TCDD and the porphyrogenic halogenated biphenyls. The regulation of both P1450 induction and porphyria by the Ah locus might seem to implicate this isoenzyme in the mechanism of porphyria. It is difficult, however, to reconcile the (modest) elevation of porphyrin excretion seen in the B6-Ahd mice in the present study with the lack Is of any detectable P1450 induction in this strain. Moreover, the induction of P1450 in the B6-Ahb mice was small compared with that seen with 3MC. In contrast, the induction of P3450 by HCB was quite striking in B6-Ahb mice, suggesting that this isoenzyme could be involved in the porphyrogenic effect of HCB. The finding that this isoenzyme was induced to a lesser extent in B6-Ahd mice is consistent with the attenuated porphyric response in this strain (cf. Table 1 and Fig. 4) . Sustained high-level induction of P3450 might be necessary for the porphyria to develop.
Conclusions
The results of the present experiments clearly indicate that the Ah locus influences the susceptibility of C57BL/ 6J mice to the porphyrogenic effects of HCB. Our study also shows that, in B6-Ah3 mice, HCB induces P1450 and P3450, which are known to be regulated by the Ah locus [50, 60] . However, unlike most compounds that interact with the Ah receptor, HCB induces P3450 preferentially. In addition, P3450 is induced to some extent in Ah-nonresponsive B6-Ahd mice, unlike P1450, which is only induced in B6-Ahb mice. Thus P3450 may be regulated by both the Ah locus and alternative mechanisms. The mechanism by which the Ah locus modulates the porphyrogenic effect of HCB is not yet clear. A decrease in UD activity has been demonstrated in porphyric mice, but it is not certain that this is the primary defect in the porphyria. Our data are consistent with the possibility that the porphyrogenic effect of HCB may be secondary to the sustained induction of P1450 and/or P3450, possibly via the production of reactive oxygen species that alter haem-biosynthetic enzymes or intermediates. Although the exact mechanism of HCB-induced porphyria remains to be elucidated, the demonstration of the involvement of the Ah locus provides evidence that all of the porphyrogenic HAHs may act by a similar mechanism. The recent demonstration that polycyclic aromatic hydrocarbon inducers of P1450 and P3450 can cause porphyria in iron-loaded C57BL/10 mice [56] provides further support for the role of the Ah locus and these cytochrome P-450 isoenzymes in this process.
